Novo Nordisk A/S

(NVO) Trade

By |

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle 1
City / Town: Bagsvaerd
Country: DK
Postal Code: DK-2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 45000
NAICS: Pharmaceutical P

Equities News

View More

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle 1
City / Town: Bagsvaerd
Country: DK
Postal Code: DK-2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 45000
NAICS: Pharmaceutical P

Equities News

View More
$ 72.68 $ -0.15 (-0.21%)
Last Price 72.68 Change $ -0.15 Change % -0.21 Tick N/A
Bid 71.90 Bid Size 100.00 Ask 73.93 Ask Size 200.00
Open 72.84 High 73.00 Low 72.39 Prev Close 72.83
Last Trade Volume 492,665 52 Wk Hi 75.87 52 Wk Low 49.25
Market Cap 167.9 bi Ex-Div Date Div Rate 1.90 Yield 2.6120
Shares 2,309,668,434.00 EPS (TTM) 2.42 PE Ratio 25.10 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 60.4 60.4 60.4 60.4
Low Target Price Estimate 60.4 60.4 60.4 60.4
Mean Target Price Estimate 60.4 60.4 60.4 60.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/29/18 05/29/18 05/03/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.13 2.3